Bridger's $456 Million Healthcare Sector Q3 Portfolio: CFN, HCA, AGN, ONXX ... Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Allergan Inc. (NYSE:AGN): On 06/30/2011, Bridger Management ... |
